70 Participants Needed

Communication Skills Training for Kidney Transplant

(EPPComm Trial)

Recruiting at 1 trial location
HM
JD
Overseen ByJoie D Cooper, MS
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Temple University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The goal of this clinical trial is to understand the communication occurring between Black and Caucasian patients and their transplant providers during transplant evaluation consultations and assess relationships between these communicative elements and patient and provider factors, patient-reported outcomes and living donor transplant outcomes - living donor referrals, evaluations, and transplants. We will use these findings to inform the development of a communication skills training for transplant providers and test the impact of the training on providers' communication about live donor kidney transplants with Black and Caucasian patients and living donor transplant outcomes.The main questions it aims to answer are:* How does the use of the use of instrumental, relational and affective communication by patients and providers during the transplant consultation differ by patient and provider factors, patient-reported outcomes and patient ethnicity?* What elements of instrumental, relational and affective communication will be predictive of live donor kidney transplant (LDKT) process outcomes (LD inquiries and evaluations, and actual LDKTs)?Participants will be asked to complete brief surveys before and after the transplant consultation and to give permission for the consultation to be audiorecorded.This data will be used to develop a training to educate providers on the key communication factors predictive of LDKT process outcomes specific to Black and Caucasian patients, and provide guidance on their application during patient consultations. Researchers will then compare communication and patient-reported and LDKT process outcomes between trained and untrained providers to see whether the training has any effect on living donor inquiries and evaluations, and actual LDKTs.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems focused on communication during transplant evaluations, so it's best to ask the trial coordinators for specific guidance on medications.

Is communication skills training safe for participants in clinical trials?

Communication skills training, like the EPPComm Provider Training, is generally considered safe for participants. It focuses on improving how healthcare professionals communicate, which can enhance patient safety and care quality without posing direct risks to participants.12345

How does the communication skills training treatment for kidney transplant differ from other treatments?

This communication skills training is unique because it focuses on improving the way patients and healthcare providers discuss kidney transplantation, which is crucial for managing the complex decisions and emotional challenges involved. Unlike traditional medical treatments, this approach enhances interpersonal communication to better support patients through the transplant process.678910

What data supports the effectiveness of the treatment EPPComm Provider Training for improving communication skills in kidney transplant patients?

Research shows that effective communication skills in nephrology, including those taught in programs like EPPComm, are crucial for improving patient care and reducing errors. Training in communication helps healthcare providers better manage discussions about kidney transplantation, which can lead to better patient outcomes.678911

Who Is on the Research Team?

FW

Francis Weng, MD

Principal Investigator

St. Barnabas Medical Center

Are You a Good Fit for This Trial?

This trial is for Black or Caucasian adults who speak English and are being evaluated for a kidney transplant at specific hospitals. It includes patients with limited English if they use a translator, but not those treated offsite or who've had previous transplants. Transplant team members involved in patient evaluations can also participate unless they decline audio recording of consultations.

Inclusion Criteria

Appear for a kidney transplant evaluation at Cooperman Barnabas Medical Center (CBMC) or Temple University Hospital (TUH)
Be of self-reported Black or Caucasian ethnicity
Patients evaluated at offsite satellite locations that are not actually at CBMC or TUHS
See 4 more

Exclusion Criteria

Are already listed for kidney transplant at CBMC or TUHS or at another transplant center
Patients having received an offer to donate a kidney from a family member or friend, or explicitly asked a family member or friend to consider serving as a LD
Adults unable to consent, individuals who are not yet adults (infants, children, teenagers), prisoners, and individuals who do not understand English
See 3 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Transplant Evaluation Consultation

Participants undergo transplant evaluation consultations to assess communication factors and patient-reported outcomes

1 day
1 visit (in-person)

Communication Skills Training

Transplant providers participate in a 60-minute, in-person communication skills training program

1 day
1 visit (in-person)

Follow-up

Participants are monitored for living donor inquiries, evaluations, and transplants

4 years

What Are the Treatments Tested in This Trial?

Interventions

  • EPPComm Provider Training
Trial Overview The study aims to improve how transplant providers communicate with patients about living donor kidney transplants. It will record consultations, survey participants, and then train providers based on these insights. The effect of this training on the number of living donor inquiries, evaluations, and actual transplants will be measured.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: EPPCom Provider TrainingExperimental Treatment1 Intervention
A highly engaging and interactive 60-minute, in-person communication skills training program will be developed as part of this project. Participating transplant providers will complete a brief online survey before (pre) and after (post) participating in the training.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Temple University

Lead Sponsor

Trials
321
Recruited
89,100+

Cooperman Barnabas Medical Center

Collaborator

Trials
2
Recruited
570+

St. Barnabas Medical Center

Collaborator

Trials
13
Recruited
2,800+

Published Research Related to This Trial

A review of 23 studies highlighted that healthcare professionals face challenges in effectively disclosing adverse events, indicating a need for better communication strategies and training.
Implementing specific interpersonal communication skills and fostering an open organizational culture can help healthcare professionals provide more effective and tailored disclosures to patients.
Disclosing Adverse Events in Clinical Practice: The Delicate Act of Being Open.Myren, BJ., de Hullu, JA., Bastiaans, S., et al.[2022]

Citations

[Physician-patient communication in nephrology]. [2011]
Assessing Nephrology Fellows' Skills in Communicating About Kidney Replacement Therapy and Kidney Biopsy: A Multicenter Clinical Simulation Study on Breaking Bad News. [2021]
Communicating About Choices in Transplantation (COACH). [2019]
Improving Communication Skills within the Nephrology Unit. [2019]
The Health-Care Provider's Perspective of Education Before Kidney Transplantation. [2018]
Handling of New Drug Safety Information in the Dutch Hospital Setting: A Mixed Methods Approach. [2023]
The human factor: the critical importance of effective teamwork and communication in providing safe care. [2022]
Communication skills of health-care professionals working in oncology--can they be improved? [2019]
Communication Training, Adverse Events, and Quality Measures: 2 Retrospective Database Analyses in Washington State Hospitals. [2023]
Disclosing Adverse Events in Clinical Practice: The Delicate Act of Being Open. [2022]
11.United Statespubmed.ncbi.nlm.nih.gov
Communication skills training for dialysis decision-making and end-of-life care in nephrology. [2017]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security